Biography - Guido Rasi - Executive Director of the European Medicines Agency
Tapahtuma-asiakirja - Päivämäärä Keskiviikkona | 17 syyskuuta 2014 - Kaupunki Bryssel - Maa Belgia - Päivämäärä Maanantaina | 29 syyskuuta 2014
Executive Director of the European Medicines Agency
Professor Rasi has been Executive Director of the European Medicines Agency since November 2011, and was a member of its Management Board for the three years prior to this. He was Director-General of the Italian Medicines Agency from 2008 to 2011 and a member of its Management Board from 2004 to 2008. He was made a full professor of microbiology at the University of Rome Tor Vergata in 2008. Professor Rasi holds a degree in medicine and surgery, with specialisation in internal medicine, allergology, and clinical immunology from the University of Rome. From 1978 to 1990, he worked as a physician in hospitals, research, and private practice. He is the author of more than 100 scientific publications.
The European Medicines Agency (EMA) is a decentralised agency of the European Union, located in London. EMA approves and monitors medicines placed on the EU market, with a view to protecting public health. It receives information from the competent authorities in the Member States and from pharmaceutical companies.
In 2012, EMA announced a new pro-active transparency policy, giving the broadest possible public access to clinical trial data in a user-friendly way. EMA intends to finalise a revised wording for its pro-active clinical trial data policy in October 2014.